Tanzeum decreases cardiovascular events among diabetes patients
Tuesday, October 2, 2018 - 13:30
in Health & Medicine
Albiglutide, a diabetes drug formerly marketed as Tanzeum, resulted in fewer cardiovascular events among type 2 diabetics with existing heart disease in a study in Europe.